This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Imalux Corporation Engages Advisor To Explore Strategic Options

NAPLES, Fla., Feb. 22, 2013 /PRNewswire/ -- Falls River Group LLC announces they have been engaged by Imalux Corporation, manufacturer of the FDA cleared, Niris 1300e imaging system, to pursue strategic relationships for the company in order to increase the widespread use of the system.

(Logo:  http://photos.prnewswire.com/prnh/20121211/DC27041LOGO)

A newly developed application for this amazing technology is in the imaging of vaginal mesh used in the repair of pelvic organ prolapse, as reported in the December 14, 2012 issue of OCT News. Earlier this year, the FDA issued a series of safety communications and requirements to manufacturers of vaginal mesh to do three-year follow-up studies on patients with vaginal mesh implants.  Imalux believes that by utilizing the Niris 1300e, physicians and manufacturers now have access to a valuable tool for the visualization of implanted vaginal mesh as part of the mandated post-market studies.

The company also believes the Niris technology will ultimately aid physicians in determining the need for hormonal replacement in the treatment of peri and post-menopausal women by using measurements of the vaginal epithelium.  Niris 1300e has been shown to be more accurate, less invasive, and generate more consistent results compared to other imaging technologies such as ultrasound in applications where Niris can be used to evaluate the rate of thinning of the vaginal wall as a determinant for hormone replacement therapy.

ABOUT FALLS RIVER GROUP, LLC

Falls River Group, LLC (FRG) is a Global Merger and Acquisition Advisor based in Naples, Florida. FRG, a member of IMAP (International Merger and Acquisition Partners), has successfully completed over 400 transactions with a combined enterprise value of several billion dollars. IMAP is a global partnership of leading M&A and corporate finance firms formed in 1973. IMAP is the world's most experienced middle-market M&A partnership, providing real-world solutions for M&A through the collaboration of more than 450 experienced transaction advisors and analysts working seamlessly across borders from offices located in 40 countries, globally ranked 3 rd in number of closed transactions under $500 million dollars

ABOUT IMALUX ® AND THE NIRIS® IMAGING SYSTEM

Imalux Corporation, based in Cleveland, Ohio, is a leader in the development of site of care imaging systems utilizing harmless, near-infrared light.  The Imalux technology platform, sold under the Niris® registered trademark, is based on its proprietary and patented application of Optical Coherence Tomography (OCT) to provide real-time, high resolution, cross sectional imaging of tissue microstructures.  Niris is a tool to aid in the diagnosis of a variety of diseases, early detection of abnormalities, guidance of biopsy and surgery, and post-treatment surveillance in a multitude of clinical applications.

SOURCE Imalux Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs